nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—CYP2C9—brain cancer	0.44	1	CbGaD
Probenecid—ABCC6—Etoposide—brain cancer	0.143	0.35	CbGbCtD
Probenecid—ABCC3—Etoposide—brain cancer	0.0689	0.168	CbGbCtD
Probenecid—ABCC1—Etoposide—brain cancer	0.0423	0.103	CbGbCtD
Probenecid—ABCC2—Carboplatin—brain cancer	0.0373	0.091	CbGbCtD
Probenecid—ABCC2—Etoposide—brain cancer	0.0313	0.0764	CbGbCtD
Probenecid—CYP3A4—Temozolomide—brain cancer	0.0298	0.0727	CbGbCtD
Probenecid—CYP3A4—Lomustine—brain cancer	0.0253	0.0618	CbGbCtD
Probenecid—CYP2C8—Etoposide—brain cancer	0.0151	0.0368	CbGbCtD
Probenecid—ABCB1—Etoposide—brain cancer	0.0102	0.0249	CbGbCtD
Probenecid—SLC22A8—choroid plexus—brain cancer	0.00706	0.109	CbGeAlD
Probenecid—CYP3A4—Etoposide—brain cancer	0.00612	0.0149	CbGbCtD
Probenecid—ABCC6—Podofilox—Etoposide—brain cancer	0.00317	1	CbGdCrCtD
Probenecid—SLCO1C1—ganglion—brain cancer	0.00235	0.0362	CbGeAlD
Probenecid—PANX1—telencephalon—brain cancer	0.00193	0.0297	CbGeAlD
Probenecid—Procainamide—DNMT1—brain cancer	0.00181	0.44	CrCbGaD
Probenecid—PANX1—pituitary gland—brain cancer	0.00157	0.0242	CbGeAlD
Probenecid—ABCC11—gonad—brain cancer	0.00154	0.0238	CbGeAlD
Probenecid—Haemolytic anaemia—Procarbazine—brain cancer	0.0015	0.0308	CcSEcCtD
Probenecid—SLC22A1—ganglion—brain cancer	0.0014	0.0216	CbGeAlD
Probenecid—PANX1—spinal cord—brain cancer	0.00135	0.0208	CbGeAlD
Probenecid—Alopecia—Lomustine—brain cancer	0.0013	0.0268	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00122	0.025	CcSEcCtD
Probenecid—PANX1—head—brain cancer	0.0012	0.0185	CbGeAlD
Probenecid—ABCC11—endocrine gland—brain cancer	0.00117	0.018	CbGeAlD
Probenecid—Chlorpropamide—CYP2C9—brain cancer	0.00116	0.283	CrCbGaD
Probenecid—Leukopenia—Lomustine—brain cancer	0.00115	0.0236	CcSEcCtD
Probenecid—Tolbutamide—CYP2C9—brain cancer	0.00113	0.276	CrCbGaD
Probenecid—SLC2A9—endocrine gland—brain cancer	0.0011	0.017	CbGeAlD
Probenecid—PANX1—central nervous system—brain cancer	0.0011	0.0169	CbGeAlD
Probenecid—Pollakiuria—Procarbazine—brain cancer	0.00108	0.0222	CcSEcCtD
Probenecid—PANX1—cerebellum—brain cancer	0.00107	0.0165	CbGeAlD
Probenecid—Aplastic anaemia—Temozolomide—brain cancer	0.00106	0.0218	CcSEcCtD
Probenecid—SLC16A7—telencephalon—brain cancer	0.00103	0.0159	CbGeAlD
Probenecid—Pain—Carboplatin—brain cancer	0.00102	0.021	CcSEcCtD
Probenecid—Anorexia—Lomustine—brain cancer	0.000998	0.0205	CcSEcCtD
Probenecid—Haematuria—Procarbazine—brain cancer	0.000994	0.0204	CcSEcCtD
Probenecid—Body temperature increased—Carboplatin—brain cancer	0.000946	0.0195	CcSEcCtD
Probenecid—Decreased appetite—Lomustine—brain cancer	0.00091	0.0187	CcSEcCtD
Probenecid—SLCO1C1—telencephalon—brain cancer	0.000907	0.014	CbGeAlD
Probenecid—PANX1—brain—brain cancer	0.000871	0.0134	CbGeAlD
Probenecid—Flushing—Procarbazine—brain cancer	0.000869	0.0179	CcSEcCtD
Probenecid—SLC16A7—gonad—brain cancer	0.000862	0.0133	CbGeAlD
Probenecid—SLC16A7—pituitary gland—brain cancer	0.000841	0.0129	CbGeAlD
Probenecid—Body temperature increased—Lomustine—brain cancer	0.000828	0.017	CcSEcCtD
Probenecid—Alopecia—Procarbazine—brain cancer	0.000827	0.017	CcSEcCtD
Probenecid—SLC16A7—medulla oblongata—brain cancer	0.000811	0.0125	CbGeAlD
Probenecid—SLC10A1—gonad—brain cancer	0.000805	0.0124	CbGeAlD
Probenecid—Anaemia—Procarbazine—brain cancer	0.000753	0.0155	CcSEcCtD
Probenecid—SLC16A7—midbrain—brain cancer	0.000742	0.0114	CbGeAlD
Probenecid—SLCO1C1—pituitary gland—brain cancer	0.000738	0.0114	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000737	0.0151	CcSEcCtD
Probenecid—Leukopenia—Procarbazine—brain cancer	0.000729	0.015	CcSEcCtD
Probenecid—ABCC5—telencephalon—brain cancer	0.000723	0.0111	CbGeAlD
Probenecid—ABCC6—endocrine gland—brain cancer	0.000671	0.0103	CbGeAlD
Probenecid—Vomiting—Lomustine—brain cancer	0.000666	0.0137	CcSEcCtD
Probenecid—ABCC6—head—brain cancer	0.000662	0.0102	CbGeAlD
Probenecid—SLC16A1—telencephalon—brain cancer	0.000657	0.0101	CbGeAlD
Probenecid—Pollakiuria—Temozolomide—brain cancer	0.000653	0.0134	CcSEcCtD
Probenecid—SLC16A7—endocrine gland—brain cancer	0.000651	0.01	CbGeAlD
Probenecid—SLCO1C1—midbrain—brain cancer	0.000651	0.01	CbGeAlD
Probenecid—SLC16A7—head—brain cancer	0.000643	0.0099	CbGeAlD
Probenecid—Alopecia—Hydroxyurea—brain cancer	0.00064	0.0132	CcSEcCtD
Probenecid—SLCO1C1—spinal cord—brain cancer	0.000635	0.00978	CbGeAlD
Probenecid—Anorexia—Procarbazine—brain cancer	0.000634	0.013	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000625	0.0128	CcSEcCtD
Probenecid—Nausea—Lomustine—brain cancer	0.000622	0.0128	CcSEcCtD
Probenecid—SLC10A1—endocrine gland—brain cancer	0.000608	0.00937	CbGeAlD
Probenecid—SLC10A1—head—brain cancer	0.000601	0.00925	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000589	0.0121	CcSEcCtD
Probenecid—ABCC5—pituitary gland—brain cancer	0.000588	0.00906	CbGeAlD
Probenecid—SLC16A7—central nervous system—brain cancer	0.000587	0.00904	CbGeAlD
Probenecid—Anaemia—Hydroxyurea—brain cancer	0.000583	0.012	CcSEcCtD
Probenecid—Decreased appetite—Procarbazine—brain cancer	0.000578	0.0119	CcSEcCtD
Probenecid—SLC16A7—cerebellum—brain cancer	0.000574	0.00883	CbGeAlD
Probenecid—SLCO1C1—endocrine gland—brain cancer	0.000572	0.00881	CbGeAlD
Probenecid—Pain—Procarbazine—brain cancer	0.000569	0.0117	CcSEcCtD
Probenecid—ABCC5—medulla oblongata—brain cancer	0.000568	0.00874	CbGeAlD
Probenecid—SLCO1C1—head—brain cancer	0.000565	0.00869	CbGeAlD
Probenecid—Leukopenia—Hydroxyurea—brain cancer	0.000564	0.0116	CcSEcCtD
Probenecid—SLC22A11—endocrine gland—brain cancer	0.000556	0.00855	CbGeAlD
Probenecid—SLC16A1—gonad—brain cancer	0.000549	0.00845	CbGeAlD
Probenecid—SLC10A1—central nervous system—brain cancer	0.000548	0.00844	CbGeAlD
Probenecid—Flushing—Carmustine—brain cancer	0.000543	0.0112	CcSEcCtD
Probenecid—SLC22A7—endocrine gland—brain cancer	0.000542	0.00835	CbGeAlD
Probenecid—SLC22A1—telencephalon—brain cancer	0.000541	0.00832	CbGeAlD
Probenecid—SLC16A1—pituitary gland—brain cancer	0.000535	0.00824	CbGeAlD
Probenecid—Erythema multiforme—Temozolomide—brain cancer	0.000535	0.011	CcSEcCtD
Probenecid—Urticaria—Procarbazine—brain cancer	0.000528	0.0109	CcSEcCtD
Probenecid—Body temperature increased—Procarbazine—brain cancer	0.000526	0.0108	CcSEcCtD
Probenecid—Flushing—Temozolomide—brain cancer	0.000525	0.0108	CcSEcCtD
Probenecid—SLCO1A2—telencephalon—brain cancer	0.00052	0.00801	CbGeAlD
Probenecid—ABCC5—midbrain—brain cancer	0.000519	0.00799	CbGeAlD
Probenecid—Alopecia—Carmustine—brain cancer	0.000517	0.0106	CcSEcCtD
Probenecid—SLC16A1—medulla oblongata—brain cancer	0.000517	0.00795	CbGeAlD
Probenecid—SLCO1C1—central nervous system—brain cancer	0.000515	0.00794	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Etoposide—brain cancer	0.0005	0.0103	CcSEcCtD
Probenecid—Alopecia—Temozolomide—brain cancer	0.0005	0.0103	CcSEcCtD
Probenecid—Anorexia—Hydroxyurea—brain cancer	0.000491	0.0101	CcSEcCtD
Probenecid—Hypersensitivity—Procarbazine—brain cancer	0.00049	0.0101	CcSEcCtD
Probenecid—SLC16A1—midbrain—brain cancer	0.000472	0.00727	CbGeAlD
Probenecid—Anaemia—Carmustine—brain cancer	0.000471	0.00969	CcSEcCtD
Probenecid—Pruritus—Procarbazine—brain cancer	0.00047	0.00967	CcSEcCtD
Probenecid—SLC16A7—brain—brain cancer	0.000466	0.00717	CbGeAlD
Probenecid—SLC16A1—spinal cord—brain cancer	0.000461	0.00709	CbGeAlD
Probenecid—Leukopenia—Carmustine—brain cancer	0.000456	0.00938	CcSEcCtD
Probenecid—Anaemia—Temozolomide—brain cancer	0.000455	0.00936	CcSEcCtD
Probenecid—Decreased appetite—Hydroxyurea—brain cancer	0.000447	0.0092	CcSEcCtD
Probenecid—Leukopenia—Temozolomide—brain cancer	0.000441	0.00907	CcSEcCtD
Probenecid—Pain—Hydroxyurea—brain cancer	0.00044	0.00905	CcSEcCtD
Probenecid—Dizziness—Procarbazine—brain cancer	0.00044	0.00904	CcSEcCtD
Probenecid—SLC10A1—brain—brain cancer	0.000435	0.0067	CbGeAlD
Probenecid—Erythema multiforme—Etoposide—brain cancer	0.000428	0.0088	CcSEcCtD
Probenecid—ABCC1—telencephalon—brain cancer	0.000427	0.00658	CbGeAlD
Probenecid—Vomiting—Procarbazine—brain cancer	0.000423	0.00869	CcSEcCtD
Probenecid—Flushing—Etoposide—brain cancer	0.00042	0.00864	CcSEcCtD
Probenecid—Dermatitis—Procarbazine—brain cancer	0.000419	0.00861	CcSEcCtD
Probenecid—Headache—Procarbazine—brain cancer	0.000417	0.00856	CcSEcCtD
Probenecid—SLC16A1—endocrine gland—brain cancer	0.000415	0.00638	CbGeAlD
Probenecid—SLC16A1—head—brain cancer	0.000409	0.0063	CbGeAlD
Probenecid—SLCO1C1—brain—brain cancer	0.000409	0.0063	CbGeAlD
Probenecid—SLCO1A2—medulla oblongata—brain cancer	0.000409	0.0063	CbGeAlD
Probenecid—Body temperature increased—Hydroxyurea—brain cancer	0.000407	0.00836	CcSEcCtD
Probenecid—Anaphylactic shock—Temozolomide—brain cancer	0.000402	0.00827	CcSEcCtD
Probenecid—ABCC5—cerebellum—brain cancer	0.000401	0.00618	CbGeAlD
Probenecid—Alopecia—Etoposide—brain cancer	0.0004	0.00823	CcSEcCtD
Probenecid—Anorexia—Carmustine—brain cancer	0.000397	0.00815	CcSEcCtD
Probenecid—Nausea—Procarbazine—brain cancer	0.000395	0.00812	CcSEcCtD
Probenecid—SLC22A7—brain—brain cancer	0.000388	0.00597	CbGeAlD
Probenecid—Anorexia—Temozolomide—brain cancer	0.000383	0.00788	CcSEcCtD
Probenecid—ABCC3—endocrine gland—brain cancer	0.000383	0.00589	CbGeAlD
Probenecid—Hypersensitivity—Hydroxyurea—brain cancer	0.000379	0.0078	CcSEcCtD
Probenecid—ABCC3—head—brain cancer	0.000378	0.00582	CbGeAlD
Probenecid—SLC22A6—brain—brain cancer	0.000375	0.00577	CbGeAlD
Probenecid—SLCO1A2—midbrain—brain cancer	0.000374	0.00575	CbGeAlD
Probenecid—SLC16A1—central nervous system—brain cancer	0.000374	0.00575	CbGeAlD
Probenecid—SLC16A1—cerebellum—brain cancer	0.000365	0.00562	CbGeAlD
Probenecid—SLCO1A2—spinal cord—brain cancer	0.000365	0.00561	CbGeAlD
Probenecid—Anaemia—Etoposide—brain cancer	0.000364	0.00749	CcSEcCtD
Probenecid—Decreased appetite—Carmustine—brain cancer	0.000362	0.00744	CcSEcCtD
Probenecid—ABCB1—blood vessel—brain cancer	0.000359	0.00553	CbGeAlD
Probenecid—Pain—Carmustine—brain cancer	0.000356	0.00731	CcSEcCtD
Probenecid—Leukopenia—Etoposide—brain cancer	0.000353	0.00725	CcSEcCtD
Probenecid—Decreased appetite—Temozolomide—brain cancer	0.000349	0.00719	CcSEcCtD
Probenecid—ABCC1—pituitary gland—brain cancer	0.000348	0.00535	CbGeAlD
Probenecid—ABCC3—central nervous system—brain cancer	0.000345	0.00531	CbGeAlD
Probenecid—Pain—Temozolomide—brain cancer	0.000344	0.00707	CcSEcCtD
Probenecid—SLC22A1—endocrine gland—brain cancer	0.000341	0.00525	CbGeAlD
Probenecid—Dizziness—Hydroxyurea—brain cancer	0.00034	0.007	CcSEcCtD
Probenecid—SLC22A1—head—brain cancer	0.000337	0.00518	CbGeAlD
Probenecid—Body temperature increased—Carmustine—brain cancer	0.000329	0.00676	CcSEcCtD
Probenecid—SLCO1A2—endocrine gland—brain cancer	0.000328	0.00505	CbGeAlD
Probenecid—Vomiting—Hydroxyurea—brain cancer	0.000327	0.00673	CcSEcCtD
Probenecid—ABCC5—brain—brain cancer	0.000326	0.00502	CbGeAlD
Probenecid—Dermatitis—Hydroxyurea—brain cancer	0.000324	0.00666	CcSEcCtD
Probenecid—SLCO1A2—head—brain cancer	0.000324	0.00499	CbGeAlD
Probenecid—Headache—Hydroxyurea—brain cancer	0.000322	0.00663	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—brain cancer	0.000322	0.00661	CcSEcCtD
Probenecid—Urticaria—Temozolomide—brain cancer	0.000319	0.00657	CcSEcCtD
Probenecid—Body temperature increased—Temozolomide—brain cancer	0.000318	0.00653	CcSEcCtD
Probenecid—ABCC4—endocrine gland—brain cancer	0.000316	0.00486	CbGeAlD
Probenecid—ABCC4—head—brain cancer	0.000312	0.0048	CbGeAlD
Probenecid—SLC22A8—head—brain cancer	0.000309	0.00476	CbGeAlD
Probenecid—SLC22A1—central nervous system—brain cancer	0.000307	0.00473	CbGeAlD
Probenecid—Anorexia—Etoposide—brain cancer	0.000307	0.0063	CcSEcCtD
Probenecid—Hypersensitivity—Carmustine—brain cancer	0.000306	0.0063	CcSEcCtD
Probenecid—SLC22A5—pituitary gland—brain cancer	0.000306	0.00471	CbGeAlD
Probenecid—ABCC2—endocrine gland—brain cancer	0.000306	0.00471	CbGeAlD
Probenecid—Nausea—Hydroxyurea—brain cancer	0.000306	0.00628	CcSEcCtD
Probenecid—SLC16A1—brain—brain cancer	0.000297	0.00457	CbGeAlD
Probenecid—Hypersensitivity—Temozolomide—brain cancer	0.000296	0.00609	CcSEcCtD
Probenecid—CYP2C8—pituitary gland—brain cancer	0.000296	0.00456	CbGeAlD
Probenecid—SLCO1A2—central nervous system—brain cancer	0.000296	0.00455	CbGeAlD
Probenecid—SLC22A5—medulla oblongata—brain cancer	0.000295	0.00454	CbGeAlD
Probenecid—SLCO1A2—cerebellum—brain cancer	0.000289	0.00445	CbGeAlD
Probenecid—ABCC4—central nervous system—brain cancer	0.000285	0.00438	CbGeAlD
Probenecid—Pruritus—Temozolomide—brain cancer	0.000284	0.00585	CcSEcCtD
Probenecid—SLC22A8—central nervous system—brain cancer	0.000282	0.00435	CbGeAlD
Probenecid—Decreased appetite—Etoposide—brain cancer	0.00028	0.00575	CcSEcCtD
Probenecid—Dizziness—Carmustine—brain cancer	0.000275	0.00566	CcSEcCtD
Probenecid—Pain—Etoposide—brain cancer	0.000275	0.00566	CcSEcCtD
Probenecid—ABCC3—brain—brain cancer	0.000274	0.00422	CbGeAlD
Probenecid—SLC22A5—midbrain—brain cancer	0.00027	0.00415	CbGeAlD
Probenecid—Dizziness—Temozolomide—brain cancer	0.000266	0.00547	CcSEcCtD
Probenecid—Vomiting—Carmustine—brain cancer	0.000264	0.00544	CcSEcCtD
Probenecid—SLC22A5—spinal cord—brain cancer	0.000263	0.00405	CbGeAlD
Probenecid—CYP2C19—endocrine gland—brain cancer	0.000263	0.00405	CbGeAlD
Probenecid—Dermatitis—Carmustine—brain cancer	0.000262	0.00539	CcSEcCtD
Probenecid—Headache—Carmustine—brain cancer	0.000261	0.00536	CcSEcCtD
Probenecid—Vomiting—Temozolomide—brain cancer	0.000256	0.00526	CcSEcCtD
Probenecid—Urticaria—Etoposide—brain cancer	0.000256	0.00525	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—brain cancer	0.000254	0.00523	CcSEcCtD
Probenecid—Dermatitis—Temozolomide—brain cancer	0.000253	0.00521	CcSEcCtD
Probenecid—Headache—Temozolomide—brain cancer	0.000252	0.00518	CcSEcCtD
Probenecid—Nausea—Carmustine—brain cancer	0.000247	0.00508	CcSEcCtD
Probenecid—SLC22A1—brain—brain cancer	0.000244	0.00376	CbGeAlD
Probenecid—Nausea—Temozolomide—brain cancer	0.000239	0.00491	CcSEcCtD
Probenecid—ABCC1—cerebellum—brain cancer	0.000237	0.00365	CbGeAlD
Probenecid—Hypersensitivity—Etoposide—brain cancer	0.000237	0.00487	CcSEcCtD
Probenecid—SLCO1A2—brain—brain cancer	0.000235	0.00362	CbGeAlD
Probenecid—ALB—brain—brain cancer	0.000233	0.00359	CbGeAlD
Probenecid—CYP2C8—endocrine gland—brain cancer	0.000229	0.00353	CbGeAlD
Probenecid—Pruritus—Etoposide—brain cancer	0.000228	0.00468	CcSEcCtD
Probenecid—ABCC4—brain—brain cancer	0.000226	0.00348	CbGeAlD
Probenecid—SLC22A8—brain—brain cancer	0.000224	0.00345	CbGeAlD
Probenecid—Dizziness—Etoposide—brain cancer	0.000213	0.00437	CcSEcCtD
Probenecid—SLC22A5—cerebellum—brain cancer	0.000209	0.00321	CbGeAlD
Probenecid—Vomiting—Etoposide—brain cancer	0.000205	0.00421	CcSEcCtD
Probenecid—CYP2C9—endocrine gland—brain cancer	0.000204	0.00314	CbGeAlD
Probenecid—Dermatitis—Etoposide—brain cancer	0.000203	0.00417	CcSEcCtD
Probenecid—Headache—Etoposide—brain cancer	0.000202	0.00414	CcSEcCtD
Probenecid—ABCC1—brain—brain cancer	0.000193	0.00297	CbGeAlD
Probenecid—Nausea—Etoposide—brain cancer	0.000191	0.00393	CcSEcCtD
Probenecid—ABCB1—telencephalon—brain cancer	0.000174	0.00268	CbGeAlD
Probenecid—SLC22A5—brain—brain cancer	0.000169	0.00261	CbGeAlD
Probenecid—CYP2C8—brain—brain cancer	0.000164	0.00253	CbGeAlD
Probenecid—CYP3A4—endocrine gland—brain cancer	0.000155	0.00239	CbGeAlD
Probenecid—ABCB1—gonad—brain cancer	0.000146	0.00224	CbGeAlD
Probenecid—ABCB1—pituitary gland—brain cancer	0.000142	0.00219	CbGeAlD
Probenecid—CYP3A4—central nervous system—brain cancer	0.00014	0.00216	CbGeAlD
Probenecid—ABCB1—medulla oblongata—brain cancer	0.000137	0.00211	CbGeAlD
Probenecid—ABCB1—midbrain—brain cancer	0.000125	0.00193	CbGeAlD
Probenecid—ABCB1—spinal cord—brain cancer	0.000122	0.00188	CbGeAlD
Probenecid—ABCB1—endocrine gland—brain cancer	0.00011	0.00169	CbGeAlD
Probenecid—ABCB1—head—brain cancer	0.000109	0.00167	CbGeAlD
Probenecid—ABCB1—central nervous system—brain cancer	9.91e-05	0.00153	CbGeAlD
Probenecid—ABCB1—cerebellum—brain cancer	9.69e-05	0.00149	CbGeAlD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.49e-05	0.00292	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—S100A10—brain cancer	8.18e-05	0.00281	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	8.16e-05	0.00281	CbGpPWpGaD
Probenecid—ABCB1—brain—brain cancer	7.87e-05	0.00121	CbGeAlD
Probenecid—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.74e-05	0.00266	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—BSG—brain cancer	7.73e-05	0.00266	CbGpPWpGaD
Probenecid—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	7.67e-05	0.00264	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	7.53e-05	0.00259	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	7.49e-05	0.00258	CbGpPWpGaD
Probenecid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.39e-05	0.00254	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	7.38e-05	0.00254	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	7.32e-05	0.00252	CbGpPWpGaD
Probenecid—CYP2C8—Biological oxidations—CYP2C9—brain cancer	7.31e-05	0.00252	CbGpPWpGaD
Probenecid—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	7.21e-05	0.00248	CbGpPWpGaD
Probenecid—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	7.21e-05	0.00248	CbGpPWpGaD
Probenecid—PANX1—Immune System—VAV1—brain cancer	7.09e-05	0.00244	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	7.08e-05	0.00244	CbGpPWpGaD
Probenecid—ABCC5—Disease—DTX2—brain cancer	7e-05	0.00241	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	6.89e-05	0.00237	CbGpPWpGaD
Probenecid—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.86e-05	0.00236	CbGpPWpGaD
Probenecid—SLCO1C1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.8e-05	0.00234	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.56e-05	0.00226	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	6.55e-05	0.00226	CbGpPWpGaD
Probenecid—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.52e-05	0.00225	CbGpPWpGaD
Probenecid—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.43e-05	0.00222	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	6.16e-05	0.00212	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—RELA—brain cancer	6.04e-05	0.00208	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—ERBB2—brain cancer	6e-05	0.00207	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	5.97e-05	0.00205	CbGpPWpGaD
Probenecid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	5.95e-05	0.00205	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	5.9e-05	0.00203	CbGpPWpGaD
Probenecid—PANX1—Immune System—PDGFRA—brain cancer	5.81e-05	0.002	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—BSG—brain cancer	5.76e-05	0.00198	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.71e-05	0.00197	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—SOD2—brain cancer	5.61e-05	0.00193	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	5.49e-05	0.00189	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—CTNNB1—brain cancer	5.25e-05	0.00181	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CYP2C9—brain cancer	5.17e-05	0.00178	CbGpPWpGaD
Probenecid—ABCC5—Disease—HES5—brain cancer	5.14e-05	0.00177	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.14e-05	0.00177	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	5.14e-05	0.00177	CbGpPWpGaD
Probenecid—PANX1—Immune System—IRS2—brain cancer	5.1e-05	0.00176	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TRPC6—brain cancer	5.06e-05	0.00174	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.8e-05	0.00165	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	4.79e-05	0.00165	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—TRPC6—brain cancer	4.71e-05	0.00162	CbGpPWpGaD
Probenecid—ABCC4—Platelet degranulation—VEGFA—brain cancer	4.7e-05	0.00162	CbGpPWpGaD
Probenecid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	4.48e-05	0.00154	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	4.47e-05	0.00154	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—SOD2—brain cancer	4.45e-05	0.00153	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—BSG—brain cancer	4.4e-05	0.00151	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.38e-05	0.00151	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.18e-05	0.00144	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—EGFR—brain cancer	4.16e-05	0.00143	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.06e-05	0.0014	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	4.06e-05	0.0014	CbGpPWpGaD
Probenecid—ABCC1—Disease—DTX2—brain cancer	4.05e-05	0.00139	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—RELA—brain cancer	3.98e-05	0.00137	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CYP2C9—brain cancer	3.96e-05	0.00136	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.92e-05	0.00135	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.87e-05	0.00133	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MPL—brain cancer	3.86e-05	0.00133	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—VAV1—brain cancer	3.79e-05	0.00131	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—IDH1—brain cancer	3.78e-05	0.0013	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TRPC6—brain cancer	3.78e-05	0.0013	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	3.77e-05	0.0013	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.76e-05	0.00129	CbGpPWpGaD
Probenecid—ALB—Hemostasis—S100A10—brain cancer	3.7e-05	0.00127	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CYP2C9—brain cancer	3.68e-05	0.00127	CbGpPWpGaD
Probenecid—PANX1—Immune System—RELA—brain cancer	3.52e-05	0.00121	CbGpPWpGaD
Probenecid—PANX1—Immune System—ERBB2—brain cancer	3.5e-05	0.0012	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	3.48e-05	0.0012	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.48e-05	0.0012	CbGpPWpGaD
Probenecid—ABCC5—Disease—IDH1—brain cancer	3.46e-05	0.00119	CbGpPWpGaD
Probenecid—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	3.45e-05	0.00119	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	3.41e-05	0.00117	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.38e-05	0.00117	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—BSG—brain cancer	3.37e-05	0.00116	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	3.31e-05	0.00114	CbGpPWpGaD
Probenecid—ABCC5—Disease—HEY1—brain cancer	3.28e-05	0.00113	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	3.27e-05	0.00113	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—RELA—brain cancer	3.24e-05	0.00112	CbGpPWpGaD
Probenecid—ABCC5—Disease—DLL1—brain cancer	3.22e-05	0.00111	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.21e-05	0.0011	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	3.2e-05	0.0011	CbGpPWpGaD
Probenecid—PANX1—Immune System—IL2—brain cancer	3.17e-05	0.00109	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—BSG—brain cancer	3.13e-05	0.00108	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.08e-05	0.00106	CbGpPWpGaD
Probenecid—PANX1—Immune System—CTNNB1—brain cancer	3.06e-05	0.00105	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.03e-05	0.00104	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—ENO2—brain cancer	2.99e-05	0.00103	CbGpPWpGaD
Probenecid—ABCC1—Disease—HES5—brain cancer	2.97e-05	0.00102	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP2C9—brain cancer	2.92e-05	0.00101	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IL2—brain cancer	2.92e-05	0.001	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—IDH1—brain cancer	2.9e-05	0.000997	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.000979	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VAV1—brain cancer	2.83e-05	0.000974	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.81e-05	0.000966	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.81e-05	0.000966	CbGpPWpGaD
Probenecid—ABCC4—Ectoderm Differentiation—MYC—brain cancer	2.79e-05	0.000962	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.79e-05	0.000961	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.76e-05	0.000949	CbGpPWpGaD
Probenecid—ABCC5—Disease—SHH—brain cancer	2.73e-05	0.000941	CbGpPWpGaD
Probenecid—ABCC5—Disease—ENO2—brain cancer	2.73e-05	0.000941	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.72e-05	0.000938	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.71e-05	0.000932	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—IDH1—brain cancer	2.69e-05	0.000927	CbGpPWpGaD
Probenecid—PANX1—Immune System—STAT3—brain cancer	2.67e-05	0.000918	CbGpPWpGaD
Probenecid—ALB—Hemostasis—BSG—brain cancer	2.61e-05	0.000897	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—RELA—brain cancer	2.57e-05	0.000886	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP2C9—brain cancer	2.54e-05	0.000876	CbGpPWpGaD
Probenecid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.54e-05	0.000873	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.51e-05	0.000862	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—BSG—brain cancer	2.48e-05	0.000855	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	2.48e-05	0.000855	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	2.45e-05	0.000844	CbGpPWpGaD
Probenecid—PANX1—Immune System—EGFR—brain cancer	2.42e-05	0.000834	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—PIK3CG—brain cancer	2.41e-05	0.000829	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.37e-05	0.000817	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ENO2—brain cancer	2.29e-05	0.000788	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP2C9—brain cancer	2.29e-05	0.000788	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.22e-05	0.000766	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL2—brain cancer	2.21e-05	0.000762	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.21e-05	0.000761	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.18e-05	0.000751	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.17e-05	0.000748	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—BSG—brain cancer	2.16e-05	0.000745	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.15e-05	0.000741	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—IDH1—brain cancer	2.14e-05	0.000735	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ENO2—brain cancer	2.13e-05	0.000733	CbGpPWpGaD
Probenecid—ALB—Platelet degranulation—VEGFA—brain cancer	2.13e-05	0.000732	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.08e-05	0.000717	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.05e-05	0.000707	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.04e-05	0.000702	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.03e-05	0.000697	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2e-05	0.000689	CbGpPWpGaD
Probenecid—ABCC1—Disease—IDH1—brain cancer	2e-05	0.000688	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP2C9—brain cancer	1.99e-05	0.000686	CbGpPWpGaD
Probenecid—ABCC5—Disease—VAV1—brain cancer	1.98e-05	0.00068	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—BSG—brain cancer	1.95e-05	0.00067	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.91e-05	0.000657	CbGpPWpGaD
Probenecid—ABCC1—Disease—HEY1—brain cancer	1.89e-05	0.000652	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.88e-05	0.000648	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TP53—brain cancer	1.87e-05	0.000645	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—IDH1—brain cancer	1.86e-05	0.00064	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP2C9—brain cancer	1.86e-05	0.00064	CbGpPWpGaD
Probenecid—ABCC1—Disease—DLL1—brain cancer	1.86e-05	0.00064	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.83e-05	0.000631	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PIK3CG—brain cancer	1.8e-05	0.000618	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.74e-05	0.000599	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TRPC6—brain cancer	1.71e-05	0.000588	CbGpPWpGaD
Probenecid—ABCC5—Disease—HES1—brain cancer	1.7e-05	0.000585	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—IL2—brain cancer	1.7e-05	0.000584	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—BSG—brain cancer	1.69e-05	0.000584	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ENO2—brain cancer	1.69e-05	0.000581	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—IDH1—brain cancer	1.67e-05	0.000576	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.67e-05	0.000575	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.65e-05	0.000568	CbGpPWpGaD
Probenecid—ABCC5—Disease—PDGFRA—brain cancer	1.62e-05	0.000557	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—BSG—brain cancer	1.58e-05	0.000544	CbGpPWpGaD
Probenecid—ABCC1—Disease—ENO2—brain cancer	1.58e-05	0.000544	CbGpPWpGaD
Probenecid—ABCC1—Disease—SHH—brain cancer	1.58e-05	0.000544	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.58e-05	0.000543	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.55e-05	0.000535	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.000521	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.48e-05	0.000509	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ENO2—brain cancer	1.47e-05	0.000506	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—IDH1—brain cancer	1.46e-05	0.000502	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—VEGFA—brain cancer	1.44e-05	0.000496	CbGpPWpGaD
Probenecid—ABCC5—Disease—IRS2—brain cancer	1.42e-05	0.000489	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CG—brain cancer	1.37e-05	0.000472	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.36e-05	0.000469	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—IDH1—brain cancer	1.36e-05	0.000468	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ENO2—brain cancer	1.32e-05	0.000455	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.3e-05	0.000446	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VAV1—brain cancer	1.28e-05	0.000441	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—IL2—brain cancer	1.26e-05	0.000435	CbGpPWpGaD
Probenecid—ABCC5—Disease—APC—brain cancer	1.25e-05	0.000432	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP2C9—brain cancer	1.25e-05	0.00043	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP2C9—brain cancer	1.24e-05	0.000428	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.21e-05	0.000415	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ENO2—brain cancer	1.15e-05	0.000397	CbGpPWpGaD
Probenecid—ABCC1—Disease—VAV1—brain cancer	1.14e-05	0.000393	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP2C9—brain cancer	1.12e-05	0.000384	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.11e-05	0.000382	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2C9—brain cancer	1.09e-05	0.000375	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—brain cancer	1.09e-05	0.000375	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VEGFA—brain cancer	1.07e-05	0.00037	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ENO2—brain cancer	1.07e-05	0.00037	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.07e-05	0.000367	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—BSG—brain cancer	1.06e-05	0.000366	CbGpPWpGaD
Probenecid—ALB—Metabolism—BSG—brain cancer	1.06e-05	0.000364	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.05e-05	0.000363	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000362	CbGpPWpGaD
Probenecid—ABCC1—Disease—HES1—brain cancer	9.82e-06	0.000338	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CG—brain cancer	9.77e-06	0.000336	CbGpPWpGaD
Probenecid—ABCC5—Disease—ERBB2—brain cancer	9.74e-06	0.000335	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—BSG—brain cancer	9.49e-06	0.000327	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	9.43e-06	0.000325	CbGpPWpGaD
Probenecid—ABCC1—Disease—PDGFRA—brain cancer	9.35e-06	0.000322	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.29e-06	0.00032	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—BSG—brain cancer	9.26e-06	0.000319	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—IDH1—brain cancer	9.14e-06	0.000315	CbGpPWpGaD
Probenecid—ALB—Metabolism—IDH1—brain cancer	9.09e-06	0.000313	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—BSG—brain cancer	8.65e-06	0.000298	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.54e-06	0.000294	CbGpPWpGaD
Probenecid—ABCC5—Disease—CTNNB1—brain cancer	8.52e-06	0.000293	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.36e-06	0.000288	CbGpPWpGaD
Probenecid—ABCC1—Disease—IRS2—brain cancer	8.21e-06	0.000282	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—IDH1—brain cancer	8.16e-06	0.000281	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CG—brain cancer	8.13e-06	0.00028	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—brain cancer	8.12e-06	0.000279	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—IDH1—brain cancer	7.96e-06	0.000274	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CG—brain cancer	7.75e-06	0.000267	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.44e-06	0.000256	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—IDH1—brain cancer	7.44e-06	0.000256	CbGpPWpGaD
Probenecid—ABCC5—Disease—STAT3—brain cancer	7.43e-06	0.000256	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.4e-06	0.000255	CbGpPWpGaD
Probenecid—ABCC1—Disease—APC—brain cancer	7.25e-06	0.000249	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ENO2—brain cancer	7.22e-06	0.000249	CbGpPWpGaD
Probenecid—ALB—Metabolism—ENO2—brain cancer	7.18e-06	0.000247	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.02e-06	0.000242	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—brain cancer	6.9e-06	0.000238	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—brain cancer	6.75e-06	0.000232	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CG—brain cancer	6.74e-06	0.000232	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2C9—brain cancer	6.71e-06	0.000231	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.64e-06	0.000229	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ENO2—brain cancer	6.45e-06	0.000222	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ENO2—brain cancer	6.29e-06	0.000217	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CG—brain cancer	6.07e-06	0.000209	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.06e-06	0.000209	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ENO2—brain cancer	5.88e-06	0.000202	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—brain cancer	5.72e-06	0.000197	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BSG—brain cancer	5.7e-06	0.000196	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—brain cancer	5.63e-06	0.000194	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—brain cancer	5.29e-06	0.000182	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—brain cancer	4.93e-06	0.00017	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—brain cancer	4.92e-06	0.000169	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—IDH1—brain cancer	4.91e-06	0.000169	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—brain cancer	4.86e-06	0.000167	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—brain cancer	4.29e-06	0.000148	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—brain cancer	3.99e-06	0.000137	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—brain cancer	3.9e-06	0.000134	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO2—brain cancer	3.88e-06	0.000133	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—brain cancer	3.67e-06	0.000126	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—brain cancer	3.31e-06	0.000114	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—brain cancer	3.3e-06	0.000113	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—brain cancer	2.96e-06	0.000102	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—brain cancer	2.89e-06	9.94e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—brain cancer	2.7e-06	9.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—brain cancer	1.78e-06	6.12e-05	CbGpPWpGaD
